STRYKER CORP Business Combination, Consideration Transferred
STRYKER CORP (SYK) reported Business Combination, Consideration Transferred of $2.56 billion for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-10.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationConsiderationTransferred1 · last filed 2023-05-02
- STRYKER CORP business combination, consideration transferred for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- STRYKER CORP business combination, consideration transferred for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- STRYKER CORP business combination, consideration transferred for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- STRYKER CORP business combination, consideration transferred for the quarter ending 2022-03-31 was $2.56B, a 8167.74% increase year-over-year.
- STRYKER CORP business combination, consideration transferred for fiscal 2022 was $2.56B, a 552.16% increase from fiscal 2021.
- STRYKER CORP business combination, consideration transferred for fiscal 2021 was $393.00M, a 90.87% decline from fiscal 2020.
- STRYKER CORP business combination, consideration transferred for fiscal 2020 was $4.30B, a 292.70% increase from fiscal 2019.
- STRYKER CORP business combination, consideration transferred for fiscal 2019 was $1.10B.
| Period end | Business Combination, Consideration Transferred 3 month | Business Combination, Consideration Transferred 6 month | Business Combination, Consideration Transferred 9 month | Business Combination, Consideration Transferred 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $0.00 derived: sum of 2 quarters · filed 2023-02-10 | $0.00 derived: sum of 3 quarters · filed 2023-02-10 | $2.56B 10-K · filed 2023-02-10 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $0.00 derived: sum of 2 quarters · filed 2022-11-01 | $2.56B 10-Q · filed 2022-11-01 | $2.69B derived: sum of 4 quarters · filed 2023-05-02 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $2.56B 10-Q · filed 2022-07-27 | $2.69B derived: sum of 3 quarters · filed 2023-05-02 | $2.85B derived: sum of 4 quarters · filed 2023-05-02 |
| 2022-03-31 | $2.56B 10-Q · filed 2023-05-02 | $2.69B derived: sum of 2 quarters · filed 2023-05-02 | $2.85B derived: sum of 3 quarters · filed 2023-05-02 | $2.92B derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | $126.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $285.00M derived: sum of 2 quarters · filed 2023-02-10 | $362.00M derived: sum of 3 quarters · filed 2023-02-10 | $393.00M 10-K · filed 2023-02-10 |
| 2021-09-30 | $159.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $236.00M derived: sum of 2 quarters · filed 2022-11-01 | $267.00M 10-Q · filed 2022-11-01 | $4.54B derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $77.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $108.00M 10-Q · filed 2022-07-27 | $4.39B derived: sum of 3 quarters · filed 2022-07-27 | $4.39B derived: sum of 4 quarters · filed 2022-07-27 |
| 2021-03-31 | $31.00M 10-Q · filed 2022-04-29 | $4.31B derived: sum of 2 quarters · filed 2022-04-29 | $4.31B derived: sum of 3 quarters · filed 2022-04-29 | $4.31B derived: sum of 4 quarters · filed 2022-04-29 |
| 2020-12-31 | $4.28B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $4.28B derived: sum of 2 quarters · filed 2022-02-11 | $4.28B derived: sum of 3 quarters · filed 2022-02-11 | $4.30B 10-K · filed 2022-02-11 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $3.00M derived: sum of 2 quarters · filed 2021-10-29 | $26.00M 10-Q · filed 2021-10-29 | $676.00M derived: sum of 4 quarters · filed 2021-10-29 |
| 2020-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $26.00M 10-Q · filed 2021-07-28 | $676.00M derived: sum of 3 quarters · filed 2021-07-28 | $697.00M derived: sum of 4 quarters · filed 2021-07-28 |
| 2020-03-31 | $23.00M 10-Q · filed 2021-04-28 | $673.00M derived: sum of 2 quarters · filed 2021-04-28 | $694.00M derived: sum of 3 quarters · filed 2021-04-28 | $811.00M derived: sum of 4 quarters · filed 2021-04-28 |
| 2019-12-31 | $650.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $671.00M derived: sum of 2 quarters · filed 2021-02-11 | $788.00M derived: sum of 3 quarters · filed 2021-02-11 | $1.10B 10-K · filed 2021-02-11 |
| 2019-09-30 | $21.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $138.00M derived: sum of 2 quarters · filed 2020-10-30 | $446.00M 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $117.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $425.00M 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | $308.00M 10-Q · filed 2020-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |